1-14 of 14
Paul Meyers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chromoplexy Is a Frequent Early Clonal Event in EWSR1-Rearranged Round Cell Sarcomas That Can Be Detected Using Clinically Validated Targeted Sequencing Panels

Josephine K. Dermawan, Emily Slotkin, William D. Tap, Paul Meyers, Leonard Wexler, John Healey, Fabio Vanoli, Chad M. Vanderbilt, Cristina R. Antonescu
Journal: Cancer Research
Cancer Res (2024) 84 (9): 1504–1516.
https://doi.org/10.1158/0008-5472.CAN-23-2573
Published: 02 May 2024
View article titled, Chromoplexy Is a Frequent Early Clonal Event in <em>EWSR1</em>-Rearranged Round Cell Sarcomas That Can Be Detected Using Clinically Validated Targeted Sequencing Panels
Open the PDF for Chromoplexy Is a Frequent Early Clonal Event in <em>EWSR1</em>-Rearranged Round Cell Sarcomas That Can Be Detected Using Clinically Validated Targeted Sequencing Panels in another window
Includes: Supplementary data
Journal Articles

Abstract 2590: Analysis of homologous recombination deficiency (HRD) scores in osteosarcoma

Michael David Kinnaman, Julia Pena, Max Levine, Nancy Bouvier, Elli Papaemmanuil, Suzanne Forrest, Katherine Janeway, Paul Meyers, Julia Glade Bender
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2590.
https://doi.org/10.1158/1538-7445.AM2022-2590
Published: 15 June 2022
View article titled, Abstract 2590: Analysis of homologous recombination deficiency (HRD) scores in osteosarcoma
Journal Articles

Abstract 1515: Tracking the origins and drivers of metastatic expansion in osteosarcoma

Michael David Kinnaman, Alvin Makohon-Moore, Dominik Glodzik, Max Levine, Nancy Bouvier, Filemon Dela Cruz, Meera Hameed, Paul Meyers, Elli Papaemmanuil, Andrew Kung, Christine Iacobuzio-Donahue
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1515.
https://doi.org/10.1158/1538-7445.AM2020-1515
Published: 15 August 2020
View article titled, Abstract 1515: Tracking the origins and drivers of metastatic expansion in osteosarcoma
Journal Articles

Abstract A35: A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma

Neerav Shukla, Shinji Kohsaka, Nabahet Ameur, Angela Yannes, Agnes Viale, Li-Xuan Qin, Snjezana Dogan, Raf Sciot, Julia Bridge, Paul Meyers, Leonard Wexler, Jonathan Fletcher, Marc Ladanyi
Journal: Cancer Research
Cancer Res (2014) 74 (20_Supplement): A35.
https://doi.org/10.1158/1538-7445.PEDCAN-A35
Published: 09 October 2014
View article titled, Abstract A35: A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma
Journal Articles

Abstract 2752: Novel inhibitor of HSP90- PU-H71 exhibits significant activity in Ewing sarcoma pre-clinical models.

Srikanth R. Ambati, Eloisi Caldas Lopes, Ullas Mony, Kohji Kosugi, Andre Moreira, Paul Meyers, Gabriela Chiosis, Malcolm Moore
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2752.
https://doi.org/10.1158/1538-7445.AM2013-2752
Published: 15 April 2013
View article titled, Abstract 2752: Novel inhibitor of HSP90- PU-H71 exhibits significant activity in Ewing sarcoma pre-clinical models.
Journal Articles

Abstract LB-62: Direct visualization of circulating sarcoma cells by whole-blood fluorescence in-situ hybridization

Alexei Morozov, Margaret Leversha, Mary-Louise Keohan, David R. D'Adamo, Gary K. Schwartz, Paul Meyers, Robert G. Maki, Malcolm A.S. Moore
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): LB-62.
https://doi.org/10.1158/1538-7445.AM10-LB-62
Published: 15 April 2010
View article titled, Abstract LB-62: Direct visualization of circulating sarcoma cells by whole-blood fluorescence in-situ hybridization
Journal Articles

Comparison between expression profiles of primary human osteosarcoma tumor specimen versus xenograft models and standard cell lines

Sajida Piperdi, Rui Yang, Alexander Chou, John Healey, Paul Meyers, Richard Gorlick
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4262.
Published: 01 May 2008
View article titled, Comparison between expression profiles of primary human osteosarcoma tumor specimen versus xenograft models and standard cell lines
Journal Articles

Expression of vascular endothelial growth factor correlates with chemotherapy response in osteosarcoma patients

Jun Ah Lee, Bang Hoang, Alexander Chou, Paul Meyers, John Healey, Richard Gorlick
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3489.
Published: 01 May 2007
View article titled, Expression of vascular endothelial growth factor correlates with chemotherapy response in osteosarcoma patients
Journal Articles

Over-expression of parathyroid hormone type 1 receptor correlated with relapse and metastases in osteosarcoma

Rui Yang, Bang Hoang, Rebecca Sowers, John Healey, Andrew Huvos, Paul Meyers, Richard Gorlick
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 973.
Published: 15 April 2006
View article titled, Over-expression of parathyroid hormone type 1 receptor correlated with relapse and metastases in osteosarcoma
Journal Articles

Estrogen receptor status and puberty predict outcome in osteogenic sarcoma

Jorge Casas-Ganem, Hirotaka Kawano, Saminathan S. Nathan, Rebecca Sowers, Hiroo Mizobuchi, Jose Manuel Garcia-Castellano, Paul Meyers, Andrew Huvos, John H. Healey, Richard Gorlick
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 504–505.
Published: 01 May 2005
View article titled, Estrogen receptor status and puberty predict outcome in osteogenic sarcoma
Journal Articles

Over-expression of parathyroid hormone/ related peptide receptor I correlates with relapse/metastases in osteosarcoma samples

Rui Yang, Rebecca S. Sowers, John Healey, Andruw Huvos, Paul Meyers, Richard Gorlick
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1114.
Published: 01 May 2005
View article titled, Over-expression of parathyroid hormone/ related peptide receptor I correlates with relapse/metastases in osteosarcoma samples
Journal Articles

Identification of Prognostic Markers in Bone Sarcomas Using Proton-Decoupled Phosphorus Magnetic Resonance Spectroscopy

Kristen L. Zakian, Amita Shukla-Dave, Paul Meyers, Richard Gorlick, John Healey, Howard T. Thaler, Andrew G. Huvos, David M. Panicek, Jason A. Koutcher
Journal: Cancer Research
Cancer Res (2003) 63 (24): 9042–9047.
Published: 24 December 2003
View article titled, Identification of Prognostic Markers in Bone Sarcomas Using Proton-Decoupled Phosphorus Magnetic Resonance Spectroscopy
Open the PDF for Identification of Prognostic Markers in Bone Sarcomas Using Proton-Decoupled Phosphorus Magnetic Resonance Spectroscopy in another window
Journal Articles

Absence of a Telomere Maintenance Mechanism as a Favorable Prognostic Factor in Patients with Osteosarcoma

Gary A. Ulaner, Hsuan-Ying Huang, Jesse Otero, Zhiquan Zhao, Leah Ben-Porat, Jaya M. Satagopan, Richard Gorlick, Paul Meyers, John H. Healey, Andrew G. Huvos, Andrew R. Hoffman, Marc Ladanyi
Journal: Cancer Research
Cancer Res (2003) 63 (8): 1759–1763.
Published: 15 April 2003
View article titled, Absence of a Telomere Maintenance Mechanism as a Favorable Prognostic Factor in Patients with Osteosarcoma
Open the PDF for Absence of a Telomere Maintenance Mechanism as a Favorable Prognostic Factor in Patients with Osteosarcoma in another window
Journal Articles

Phase I and Clinical Pharmacological Study of 4-Demethoxydaunorubicin (Idarubicin) in Children with Advanced Cancer

Charlotte T. C. Tan, Counce Hancock, Peter Steinherz, David M. Bacha, Laurel Steinherz, Enrique Luks, Naomi Winick, Paul Meyers, Anna Mondora, Ester Dantis, Donna Niedzwiecki, Yee-Wan Stevens
Journal: Cancer Research
Cancer Res (1987) 47 (11): 2990–2995.
Published: 01 June 1987
View article titled, Phase I and Clinical Pharmacological Study of 4-Demethoxydaunorubicin (Idarubicin) in Children with Advanced Cancer
Open the PDF for Phase I and Clinical Pharmacological Study of 4-Demethoxydaunorubicin (Idarubicin) in Children with Advanced Cancer in another window